Literature DB >> 22217235

Influence of gender and estrous cycle on plasma and renal catecholamine levels in rats.

Helena L Gomes1, Jones B Graceli, Washington L S Gonçalves, Roger L dos Santos, Gláucia R Abreu, Nazaré S Bissoli, José G P Pires, Maria A Cicilini, Margareth R Moysés.   

Abstract

Several studies have demonstrated that gonadal hormones show significant effects on the brain and signaling pathways of effector organs/cells that respond to neurotransmitters. Since little information is available concerning the impact of male and female gonadal hormones on the renal and peripheral sympathetic system, the objective of this study was to further assess whether and how the renal content and plasma concentration of catecholamines are influenced by gender and the estrous cycle in rats. To achieve this, males Wistar rats were divided into 4 groups: (i) sham (i.e., control), (ii) gonadectomized, (iii) gonadectomized and nandrolone decanoate replacement at physiological levels or (iv) gonadectomized and nandrolone decanoate replacement at high levels. Female Wistar rats were divided into 6 groups: (i) ovariectomized (OVX), (ii) estrogen replacement at physiological levels and (iii) estrogen replacement at at high levels, (iv) progesterone replacement at physiological levels and (v) progesterone replacement at at high levels, and (vi) sham. The sham group was subdivided into four subgroups: (i) proestrus, (ii) estrus, (iii) metaestrus, and (iv) diestrus. Ten days after surgery, the animals were sacrificed and their plasma and renal catecholamine levels measured for intergroup comparisons. Gonadectomy led to an increase in the plasma catecholamine concentration in females, as well as in the renal catecholamine content of both male and female rats. Gonadectomized males also showed a lower level of plasma catecholamine than the controls. The urinary flow, and the fractional excretion of sodium and chloride were significantly increased in gonadectomized males and in the OVX group when compared with their respective sham groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22217235     DOI: 10.1139/y11-102

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

1.  Estrogen deficiency compromised the β2AR-Gs/Gi coupling: implications for arrhythmia and cardiac injury.

Authors:  Hongjian Hou; Zhiwei Zhao; Jeremiah Ong'achwa Machuki; Lin Zhang; Yan Zhang; Lu Fu; Jinxia Wu; Yuyu Liu; Sian E Harding; Hong Sun
Journal:  Pflugers Arch       Date:  2018-01-02       Impact factor: 3.657

2.  Skeletal phenotype of the neuropeptide Y knockout mouse.

Authors:  Natalie K Y Wee; Benjamin P Sinder; Sanja Novak; Xi Wang; Chris Stoddard; Brya G Matthews; Ivo Kalajzic
Journal:  Neuropeptides       Date:  2018-11-30       Impact factor: 3.286

3.  Breaking the Cycle: Estrous Variation Does Not Require Increased Sample Size in the Study of Female Rats.

Authors:  Alex Dayton; Eric C Exner; John D Bukowy; Timothy J Stodola; Theresa Kurth; Meredith Skelton; Andrew S Greene; Allen W Cowley
Journal:  Hypertension       Date:  2016-09-26       Impact factor: 10.190

4.  Roles of estrogen and progesterone in modulating renal nerve function in the rat kidney.

Authors:  J B Graceli; M A Cicilini; N S Bissoli; G R Abreu; M R Moysés
Journal:  Braz J Med Biol Res       Date:  2013-07-02       Impact factor: 2.590

Review 5.  Obesity: sex and sympathetics.

Authors:  Zhigang Shi; Jennifer Wong; Virginia L Brooks
Journal:  Biol Sex Differ       Date:  2020-03-11       Impact factor: 5.027

Review 6.  Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular Diseases.

Authors:  Daniela Liccardo; Beatrice Arosio; Graziamaria Corbi; Alessandro Cannavo
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

7.  Testosterone Replacement Therapy Prevents Alterations of Coronary Vascular Reactivity Caused by Hormone Deficiency Induced by Castration.

Authors:  Wender Nascimento Rouver; Nathalie Tristão Banhos Delgado; Jussara Bezerra Menezes; Roger Lyrio Santos; Margareth Ribeiro Moyses
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.